798. The Successful Recovery of Bacteriophages with Activity against Vancomycin-Resistant Enterococci (VRE) from Stool Samples of Hematopoietic Cell Transplant (HCT) Recipients
Session: Poster Abstract Session: Treatment of Resistant Infections - Clinical Analyses
Thursday, October 5, 2017
Room: Poster Hall CD

Background: Vancomycin-resistant Enterococci (VRE) is a well-known infectious complication among immunocompromised patients. VRE colonization of the gastro-intestinal (GI) tract could be associated with VRE bacteremia and worse outcome in hematopoietic cell transplant (HCT) recipients, in particular. Eradication of VRE colonization with systemic antibiotics is strongly discouraged for many reasons including lack of efficacy, rapid onset of resistance to the particular antibiotic used, and disruption of the normal site flora. Bacteriophages (phages) may constitute a good alternative to antibiotics to eliminate specific pathogens without disturbing the patient’s normal flora. Phages are the most abundant organisms in the biosphere. They are naturally occurring entities that play a critical role in maintaining microbial balance in every ecosystem where bacteria are present.

Methods: Nine HCT recipients were enrolled in this study including 5 with no VRE infection or colonization, 3 with detected VRE colonization of the GI tract, and 1 with confirmed VRE bacteremia. One-time stool samples were obtained and screened for the presence of VRE-specific phages. Individual phage plaques were then harvested, amplified, and characterized. The recovered phages were tested against VRE strains isolated from the same stool samples.

Results: Five different phages were isolated from stool samples (Fig. 1A-C). All phages were able to eradicate at least one of these VRE strains (Fig. 1D). The action of some of these phages complemented one another. Phages 1 and 5 as well as phages 2 and 4 could form cocktails active against all these VRE strains.

Conclusion: Our results highlight the feasibility and the potential success of these phages in eradicating VRE in vitro and in vivo. The isolation of phages directly from patients’ stool samples is a novel approach to obtain naturally-occurring phages already present in the gut. These VRE-specific phage cocktails may be used in future studies to eliminate VRE colonization and subsequent infections in HCT recipients.

Lynn El Haddad, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, Mark Stibich, PhD, MHS, Xenex Healthcare Services, LLC, Houston, TX and Roy F. Chemaly, MD, MPH, FIDSA, FACP, University of Texas M.D. Anderson Cancer Center, Houston, TX


L. El Haddad, None

M. Stibich, None

R. F. Chemaly, None

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.